This upregulation was accompanied by increased expression of multiple inhibitory ICPs (e.g., PD-L1, B7-H3, and CD47) compared with their parental adherent cells (cancer), suggesting a potential role for these ICPs in mediating CSC characteristics. The gene discussed is CD276; the disease is cancer.